Evaluation of GATA3 and HER-2 Immunohistochemical Expression as Prognostic Markers in Urothelial Carcinoma of the Urinary Bladder.
OBJECTIVE Urothelial carcinoma (UC) of the bladder remains a significant clinical challenge due to its high rates of recurrence and progression. Reliable biomarkers to predict tumor behaviour are still needed. GATA3 and HER2 have gained attention in this context, but their combined prognostic value has not been fully e...